| Melissa Anne Urian, PHARMD | |
|
103 S Dupont Blvd Ste 2, Smyrna, DE 19977-1549 | |
| (302) 653-9355 | |
| (302) 653-9388 |
| Full Name | Melissa Anne Urian |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 103 S Dupont Blvd Ste 2, Smyrna, Delaware |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497277560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | A1-0005013 (Delaware) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Anne Urian, PHARMD 615 Holletts Corner Rd, Clayton, DE 19938-2934 Ph: (302) 535-0266 | Melissa Anne Urian, PHARMD 103 S Dupont Blvd Ste 2, Smyrna, DE 19977-1549 Ph: (302) 653-9355 |
News Archive
Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering weekly research-based tip sheets regarding breast cancer prevention, screening and early detection, treatment and survivorship.
The Pennsylvania Human Relations Commission issued an order today dismissing a racial discrimination complaint filed by Maria Thompson-White of Merchantville, New Jersey, against her former employer, Lycoming House, a drug addiction treatment center in Philadelphia.
The number of cases of invasive pneumococcal disease (IPD) in children has fallen since the introduction of a new vaccine a year ago. Enhanced surveillance by the UK's Health Protection Agency has shown that cases of IPD caused by the seven major types of the pneumococcus bacteria which the new pneumococcal conjugate vaccine (PCV) protects against have gone down by almost 50%.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.
› Verified 4 days ago
Ms. Ami Parikh, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Sunnyside Rd, Smyrna, DE 19977 Phone: 302-223-1370 Fax: 302-653-0506 | |
Ms. Taryn Marie Callahan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Jimmy Dr, Smyrna, DE 19977 Phone: 302-653-8528 | |
Mrs. Bonita D Buesmaill, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13 Borealis Ct, Smyrna, DE 19977 Phone: 302-659-1639 Fax: 302-659-1639 | |
Daniel E Dagadu, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 Jimmy Drive, Walgreens Store 11134 700 Jimmy Drive, Smyrna, DE 19977 Phone: 302-653-8528 | |
Dr. Hooshang Shanehsaz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Sunnyside Rd, Smyrna, DE 19977 Phone: 302-223-1370 Fax: 302-223-1090 | |
Alison Panicola, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 236 E Glenwood Ave, Smyrna, DE 19977 Phone: 302-653-3610 Fax: 302-653-3614 | |
Dr. Abigail Elise Weber, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 315 N Carter Rd, Smyrna Anticoagulation Clinic, Smyrna, DE 19977 Phone: 302-653-0927 Fax: 302-653-0928 |